Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
We use essential cookies by default: sign-in, your choice in this banner (supstack-consent) and your language (NEXT_LOCALE). Vercel Web Analytics (cookieless page counts) and Sentry error reports (without replay) run either way. Only if you choose "Accept all" do we also create a browser ID in local storage (it ties your visits together in our site records), record error-replay diagnostics (Sentry: masked DOM snapshots, only when an error fires) and turn on load-time metrics (Vercel Speed Insights) so we can fix slow pages faster. Learn more about cookies
All 4791 database studies by type: RCT 3205 · Meta-Analysis 1062 · Systematic Review 426 · Review 94 · other 4
What the evidence says
Helped
Probiotics helped in 16 of 21 studies that measured an effect.
Most evidence is from high-quality meta-analyses and randomised trials published 2012–2027 with a typical study size of 1,009 participants.
Based on 1,028 studies · 282 meta-analyses · 580 RCTs · 34,923 total participants · 3,763 more studies listed but not graded here
Study base
1,028 studies indexed
What the studies found
16helped4unclear1didn't help· 1007 more without graded effect data
By outcome
Digestive healthImproved gut microbiome balance and digestive regularity within 2-4 weeksHelped859 studies
Helped859 studies
Therapeutic & clinicalHelped169 studies
Helped169 studies
Women's healthA Cochrane review found no clear effect on gestational diabetes, and a higher risk of pre-eclampsia with probiotics (4 trials, 955 women, high-certainty evidence) · OngoingToo few graded studies88 studies
Too few graded studies88 studies
Depression & moodReductions in depression symptoms in clinical samples; anxiety benefit is inconsistent and strain-/population-dependent · 4-8 weeksHelped54 studies
Helped54 studies
Glucose & metabolicToo few graded studies50 studies
Too few graded studies50 studies
Weight managementToo few graded studies47 studies
Too few graded studies47 studies
Cognitive functionToo few graded studies40 studies
Too few graded studies40 studies
Anxiety & stressAnxiety evidence is mixed — meta-analyses are null in general populations, with benefit mainly in clinically diagnosed samples · 4-8 weeksToo few graded studies26 studies
Too few graded studies26 studies
Skin healthToo few graded studies19 studies
Too few graded studies19 studies
Immune supportMay reduce frequency and duration of respiratory infections · 4-8 weeksToo few graded studies17 studies
Too few graded studies17 studies
InflammationMulti-strain probiotics help induce and maintain remission in ulcerative colitis and pouchitis in RCT meta-analyses, with smaller benefits in periodontitis and allergic rhinitis · 2-4 weeksToo few graded studies17 studies
Too few graded studies17 studies
Safety profileToo few graded studies16 studies
Too few graded studies16 studies
Liver healthToo few graded studies14 studies
Too few graded studies14 studies
Heart & blood pressureToo few graded studies13 studies
Too few graded studies13 studies
Bone healthToo few graded studies9 studies
Too few graded studies9 studies
Joint pain & arthritisToo few graded studies7 studies
Too few graded studies7 studies
Cholesterol & lipidsToo few graded studies6 studies
Too few graded studies6 studies
Energy & fatigueToo few graded studies5 studies
Too few graded studies5 studies
Fertility & reproductiveToo few graded studies5 studies
Too few graded studies5 studies
Sleep & insomniaToo few graded studies4 studies
Too few graded studies4 studies
Vision & eye healthToo few graded studies1 study
Too few graded studies1 study
By the numbers
Pulled from 113 studies with measurable effects
Likely real effects
84%
across studies
People studied
35k
typical study: 1009 people
Strongest designs
862
282 pooled, 580 randomised
Showed benefit
76%
16/21 studies
How long studies ran
1–4 weeks
5
1–3 months
21
3+ months
4
Populations Studied
General population4
Type 2 diabetes patients2
Cancer patients2
Adults2
Active research area
1,018 studies in the last 5 years · Latest meta-analysis: 2026
201220192027
1Meta-Analysis2026
In plain English: Oral probiotic supplementation lowers the levels of some inflammatory markers in patients with autoimmune diseases.
Chiou YY, Chiu TY, Chen MJ. · Nutrients (2026)
Background Autoimmune diseases affect 5-10% of the global population.
Subgroup analysis revealed that in rheumatoid arthritis (RA) patients, the probiotics group showed greater improvements in IL-6, IL-1β, and TNFα compared to the controls.
In multiple sclerosis (MS) patients, the probiotics group demonstrated greater improvements in hs-CRP.
2Intestinal barrier function improvementMeta-AnalysisCited 149×n=1,891 · large study2023
In plain English: Meta-analysis of data from a total of 26 RCTs (n = 1891) indicated that probiotics significantly improved gut barrier function measured by levels of TER (MD, 5.27, 95% CI, 3.82 to 6.72, P < 0.00001), serum zonulin (SMD, -1.58, 95% CI, -2.49 to -0.66, P = 0.0007), endotoxin (SMD, -3.20, 95% CI, -5.41 to -0.98, P = 0.005), and LPS (SMD, -0.47, 95% CI, -0.85 to -0.09, P = 0.02).
Zheng Y et al. · Frontiers in Immunology (2023)
Significant improvement in intestinal barrier markers
Reduced zonulin and endotoxin levels
Enhanced gut barrier integrity across multiple trials
3FEV1 in asthma patientsMeta-AnalysisCited 10×n=1,101 · large study2023
In plain English: the use of probiotics in patients with asthma can improve lung inflammation and asthma symptoms, reduce the number of asthma attacks, and have no effect on lung function.
Xie Q et al. · Nutricion hospitalaria (2023)
No clear effect
← WorseNo effectBetter →
Meta-analysis was performed using Revman 5.4 software and the combined effect was evaluated by odds ratio (OR) or mean difference (MD) and 95 % confidence interval (CI).
There was no significant difference in forced expiratory volume in the first second (FEV1) (MD = 0.11, 95 % CI: -0.05, 0.26) and FEV1/FVC (%) (MD = 0.32, 95 % CI: -1.48, 2.12).
Results: a total of ten references were included, all of which were randomized controlled studies, and a total of 1,101 people were investigated.
4Inflammatory bowel disease outcomesMeta-AnalysisCited 52×n=2,500 · very large study2024
In plain English: Probiotics, particularly multi-strain formulations, appear efficacious for the induction of clinical remission and the prevention of relapse in UC patients as well as for relapsing pouchitis.
Estevinho MM et al. · United European Gastroenterology Journal (2024)
5Pathogenic bacteria decolonizationMeta-AnalysisCited 51×n=2,871 · very large study2024
In plain English: However, more clinical outcomes are required on particular strains to confirm the decolonization of the pathogens.
Rahman MN et al. · Gut microbes (2024)
Large benefit
← WorseNo effectBetter →
Likely real
This review aims to analyze available evidence from human-controlled trials to determine the effect size of probiotic interventions in decolonizing AMR pathogenic bacteria from the gut.
The persistence of pathogenic bacteria after treatment was 22%(probiotics) and 30.8%(placebo).
A review pooling different probiotic interventions reported lower odds of persistence of the studied gut pathogens versus control (OR 0.59; 95% CI 0.43–0.81), with moderate certainty as rated by the review authors. Statistical heterogeneity was about I² = 49%. This pooled result is not specific to one probiotic strain or product.
7Prevention of antibiotic-associated diarrheaMeta-AnalysisCited 26×n=4,691 · very large study2022
In plain English: We recommend that elderly individuals could be routinely distributed probiotics to prevent AAD development when receiving antibiotic treatment.
Zhang L et al. · BMC geriatrics (2022)
Meta-analysis of 8 randomised trials (4,691 people over 65) of probiotics to prevent antibiotic-associated diarrhoea.
Two large trials that started probiotics more than 48 hours after the first antibiotic dose found no effect and were excluded.
In the other 6 trials, probiotics started within two days of antibiotics lowered the rate of diarrhoea. The review was not registered.
8ASD behavioral symptoms improvementMeta-AnalysisCited 26×n=318 · medium study2024
In plain English: Our study highlighted the significant improvement in ASD behavioral symptoms through probiotic supplementation.
Soleimanpour S et al. · Journal of psychiatric research (2024)
The abstract reports a pooled improvement in ASD behavioural symptoms, but its printed confidence interval does not contain its estimate, so the size and significance of the effect are withheld until the full text confirms them.
The abstract reports improvements with both multi-strain and single-strain probiotics, but its printed intervals do not contain their estimates, so the numbers are withheld until the full text confirms them.
The authors concluded that probiotic supplementation significantly improved ASD behavioural symptoms. That conclusion rests on the results withheld above.
10Oral mucositis incidenceMeta-AnalysisCited 43×n=708 · large study2022
In plain English: We recommend the use of probiotics to prevent and treat oral mucositis during cancer therapy.
Liu YC et al. · International journal of molecular sciences (2022)
Noticeable benefit
← WorseNo effectBetter →
Likely real
Three trials using Lactobacilli-based probiotics reported that the incidence of oral mucositis in the probiotic group was significantly low (risk ratio [RR] = 0.84, 95% confidence interval [CI] = 0.77−0.93, p = 0.0004).
Seven trials reported a significantly low incidence of severe oral mucositis in the probiotic group (RR = 0.65, 95% CI = 0.53−0.81, p < 0.0001).
The requirement of enteral nutrition was significantly low in the probiotic group (odds ratio = 0.34, 95% CI: 0.13−0.92, p < 0.05).
12Anxiety symptomsMeta-AnalysisCited 82×n=1,527 · large study2018
In plain English: Probiotics did not significantly reduce symptoms of anxiety in humans (Hedges' g = -0.12, 95% CI -0.29-0.05, p = 0.151), and did not differentially affect clinical and healthy human samples.
Reis DJ et al. · PLoS One (2018)
Probiotics reduced anxiety-like behavior in animal models, mainly in diseased animals
No significant reduction in anxiety symptoms in human clinical trials
Only L. rhamnosus showed anxiolytic effects preclinically, in under-powered analyses